Will Richmond is a patient-centric commercial leader with extensive experience in the pharmaceutical industry. They served as the Head of Value & Access for US Rare Disease and Rare Blood Disorders at Genzyme from 2015 to 2025, and have held various leadership roles including Vice President of Market Access at Vericel® Corporation since 2025. Will's previous roles include Product Manager at Bristol-Myers Squibb and Director of Marketing at Santhera Pharmaceuticals Ltd. They earned an MBA from Cornell University and hold degrees from the University at Buffalo and Rochester Institute of Technology, while currently pursuing further education at The London School of Economics.
This person is not in any teams
This person is not in any offices